Management of Soft Tissue Sarcoma, 2nd Edition provides the most comprehensive analysis of demographics and natural history currently available for these lesions, based on the authors experience with over 10,000 patients. Sections regarding radiation therapy not found in the previous text have been expanded, as have updates on molecular characteristics of sarcomas and chemotherapy studies published since the prior edition. Clinical and molecular diagnoses are addressed, and tumor histopathology is employed as the basis of treatment recommendations including surgery, radiation and systemic therapy. This is the first book to provide specific chemotherapy opinions for every sarcoma subtype. Written by four world-renowned experts, this book gives a practical, up-to-date approach to managing the many subtypes of adult soft tissue sarcoma.
Reviews from the first edition:
This is an impressive book. Written by a surgeon, a pathologist and an oncologist, the book draws heavily on the Memorial Sloan-Kettering Cancer Center soft tissue sarcoma (STS) database. it is a book that should be in the library of any sarcoma unit and will appeal to the sub-specialist in Orthopaedic Oncology. (Robert U. Ashford, European Journal of Orthopaedic Surgery& Traumatology, Vol. 24, 2014)
The book is laid out in 27 chapters, with an impressive inclusion of a wide array of sarcoma histology. One of the real strengths of the book is the quality and number of images, figures, tables, and graphs. The overall outline of the text is well done. This book is a unique and important addition to the sarcoma literature. this edtion should find itself on every medical oncologists bookshelf . (Larry C. Daugherty and Sanjay P. Bagaria, Journal of Radiation Oncology, Vol. 3, 2014)

Murray F. Brennan, MDInternational Center& Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew York, NY
Cristina R. Antonescu, MDDepartment of PathologyMemorial Sloan-Kettering Cancer CenterNew York, NY
Kaled M. Alektiar, MDDepartment of Radiation OncologyMemorial Sloan-Kettering Cancer CenterNew York, NY
Robert G. Maki, MD, PhDGreat Neck, NY

Cold Spring Harbor Laboratory Cold Spring Harbor, NY

Part I Introduction.- 1.General Description.- 2.Natural History Importance of Size, Site, Histopathology.- 3.General Statement as to Efficacy Surgery / Chemotherapy / Radiation Therapy.- Part II  Management by Histopathology.- 4.Gastrointestinal stromal tumor.- 5.Liposarcoma.- 6.Leiomyosarcoma.- 7.Undifferentiated Pleomorphic Sarcoma (UPS) (Malignant Fibrous Histiocytoma: MFH) Myxofibrosarcoma.- 8.Synovial Sarcoma.- 9.Malignant Peripheral Nerve Sheath Tumor (MPNST) / Triton Tumor.- 10.Desmoid Tumor / Deep-Seated Fibromatosis (Desmoid-Type Fibromatosis).- 11.Solitary Fibrous Tumor / Hemangiopericytoma.- 12.Fibrosarcoma and its Variants.- 13.Vascular Sarcomas.- 14.Epithelioid Sarcoma.- 15.Sarcomas More Common in Children.- 16.Radiation-Induced Sarcoma.- 17.Alveolar Soft Part Sarcoma.- 18.Clear Cell Sarcoma / Melanoma of Soft Parts.- 19.Desmoplastic Small Round Cell Tumor.- 20.Extraskeletal Myxoid Chondrosarcoma.- 21.Other Uterine Sarcomas.- 22.Extraskeletal OsteogenicSarcoma.- 23.Sustentacular Tumors of Lymph Tissue Follicular Dendritic Cell Tumor (Dendritic Reticulum Cell Tumor [FDCT]) and Interdigitating Reticulum Cell Tumor (IDRCT).- 24.Uncommon / Unique Sites Heart and Great Vessels.- 26.Benign Tumors.- 27.Reactive Lesions.